Dan Zhang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Anti Inflammatory

Oxide Nanoparticles

Mesenchymal Stem Cells

Top Venues

Journal of neuro-oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Shizun Wang, Dan Zhang, Jialin Wang, Xiaojiao Peng, Hailang Sun, Yuanqi Ji, Zhenli Yang, Xiaocui Bian, Yuhong Hou, Ming Ge, Yuqin Liu
PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor. Journal of neuro-oncology (2024)
Shizun Wang, Dan Zhang, Jialin Wang, Xiaojiao Peng, Hailang Sun, Yuanqi Ji, Zhenli Yang, Xiaocui Bian, Yuhong Hou, Ming Ge, Yuqin Liu
PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor. Journal of neuro-oncology 168 (1) (2024)
Shizun Wang, Dan Zhang, Jialin Wang, Xiaojiao Peng, Hailang Sun, Yuanqi Ji, Zhenli Yang, Xiaocui Bian, Yuhong Hou, Ming Ge, Yuqin Liu
PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor. Journal of neuro-oncology 168 (1) (2024)
Shizun Wang, Dan Zhang, Jialin Wang, Xiaojiao Peng, Hailang Sun, Yuanqi Ji, Zhenli Yang, Xiaocui Bian, Yuhong Hou, Ming Ge, Yuqin Liu
PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor. Journal of neuro-oncology 168 (1) (2024)
Shizun Wang, Dan Zhang, Jialin Wang, Xiaojiao Peng, Hailang Sun, Yuanqi Ji, Zhenli Yang, Xiaocui Bian, Yuhong Hou, Ming Ge, Yuqin Liu
PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor. Journal of neuro-oncology 168 (1) (2024)